BridgeMD
New treatment option for Chronic Stroke Patients
Official title Mobile Applications for Exercise Adherence and Hand Function in Chronic Stroke.
ClinicalTrials.gov ID: NCT06696885
What this study is testing
- What it's testing
- Stroke is a clinically defined syndrome characterized by an acute, focal neurological deficit due to vascular damage in the central nervous system. It is the second leading cause of death and disability globally.
- Time commitment: about 10 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 75
You may be able to join if
- Male and female patients age 30 to 75 years were included.
- Chronic stroke patients ranging from 6 months to 2 years (41).
- Participants having a stroke severity score \> 6 on National Institute of Health Stroke Scale (NIHSS) (42).
- Modified Ashworth scale score ≤ 3 of the affected upper extremity (44).
- Montreal Cognitive Assessment (MoCA) score ≥ 26 (45).
You likely can't join if
- Participants who show the symptoms of global or receptive aphasia.
- Participants who have medical problems or co-morbidities that interdict their participation in the study (such as shoulder pain in the paretic limb).
- Patients with severe apraxia, somatosensory problems.
- Severe spasticity of the affected wrist and finger flexors.
See the full eligibility criteria
- Male and female patients age 30 to 75 years were included.
- Chronic stroke patients ranging from 6 months to 2 years (41).
- Participants having a stroke severity score \> 6 on National Institute of Health Stroke Scale (NIHSS) (42).
- Modified Ashworth scale score ≤ 3 of the affected upper extremity (44).
- Montreal Cognitive Assessment (MoCA) score ≥ 26 (45).
- Patients who are able to sit without support.
- No contractures of the affected wrist and fingers.
- Participants who show the symptoms of global or receptive aphasia.
- Participants who have medical problems or co-morbidities that interdict their participation in the study (such as shoulder pain in the paretic limb).
- Patients with severe apraxia, somatosensory problems.
- Severe spasticity of the affected wrist and finger flexors.
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.